Dopamine D2 agonist priming in intact and dopamine-lesioned rats

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

Robert Freedman, Hilary Coon, Marina Myles‐Worsley et al. · Proceedings of the National Academy of Sciences · 1997 · 1.1K citations

Life Sciences, Genetics, Psychiatry +16

Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

Robert Freedman, Michael E. Hall, Lawrence E. Adler et al. · Biological Psychiatry · 1995 · 679 citations

Life Sciences, Neurobiology, Neuroscience +11

Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.

Robert Freedman, Adler Le, Waldo Mc et al. · PubMed · 1983 · 473 citations

Medicine, Neuroscience, Psychiatry +13

Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.

G R Breese, Anna Baumeister, Thomas J. McCown et al. · Journal of Pharmacology and Experimental Therapeutics · 1984 · 295 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Biphasic effect of D-2 agonist quinpirole on locomotion and movements

David Eilam, Henry Szechtman · European Journal of Pharmacology · 1989 · 253 citations

Medicine, Neuroscience, Pharmacology +12